NCT01405456View on ClinicalTrials.gov

Eplerenone in HIV Associated Abdominal Fat Accumulation

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 3, 2017

Study Completion Date

November 1, 2017

Conditions
HIV
Interventions
DRUG

Eplerenone and lifestyle

eplerenone 50mg by mouth daily as well as lifestyle counseling

OTHER

placebo and lifestyle

placebo pill daily and lifestyle counseling

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01405456 - Eplerenone in HIV Associated Abdominal Fat Accumulation | Biotech Hunter | Biotech Hunter